The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Gut microbiota alterations are important in irritable bowel syndrome (IBS). The aim was to investigate the effect of fecal microbiota transplantation (FMT) on gut microbiota and the symptoms in patients with IBS. MATERIAL AND METHODS: The study included 13 IBS patients according to Rome III criteria and 13 healthy donors. Freshly donated feces were administered to the descending part of the duodenum via a gastroscope. Feces were collected from donors and patients before FMT, and from the patients at 1, 3 and 12 weeks and donors and patients at 20/28 weeks after FMT. Microbiota analysis was performed using GA-map Dysbiosis test (Genetic Analysis AS, Oslo, Norway). The patients completed the following questionnaires before and at the aforementioned weeks after FMT: IBS Symptom Questionnaire (IBS-SQ), IBS-Symptom Severity Scoring system (IBS-SSS), Short Form of Nepean Dyspepsia Index (SF-NDI), Bristol stool form scale, the Eysenck Personality Questionnaire-Neuroticism and Hospital Anxiety and Depression. RESULTS: Donors and IBS patients had significantly different bacterial strain signals before FMT (Ruminococcus gnavus, Actinobacteria and Bifidobacteria) that became non-significant after 3 weeks following FMT. The changes in gut microbiota were similar between donors and patients at 20/28 weeks after FMT. Thus, patients' microbiota profiles became more-or-less similar to donors. The scores of all the questionnaires were significantly improved at all time points following FMT. No reported adverse effects. CONCLUSIONS: FMT was associated with a change in gut microbiota and improvement in IBS symptoms and quality of life lasting for up to 28 weeks. TRIAL REGISTRATION: ClinicalTrials.gov ID: NCT03333291.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“but the majority found this to be transient (Xie et al. 2019 [45]; H. L. Huang et al. 2019 [46]; Mazzawi et al. 2018 [44]; Mizuno et al. 2017 [47]).”
From Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review (2020) · cites this paper as Mazzawi et al. 2018 [44]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“Only Mazzawi et al. [92] and Kurokawa et al. [95] performed the FDR correction.”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [92]
In the citing paper
“The long-term effects were less consistent, with three studies finding a return to baseline at week 12, week 20, and month 6 respectively [44–46].”
From Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review (2020) · cites this paper as [46]
In the citing paper
“A significant decrease in EPQ-N-12 scores was seen at week 3, but this returned to baseline by week 20 [46].”
From Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review (2020) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Stool form scale as a useful guide to intestinal transit time
Lewis, S. J., & Heaton, K. W. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011203 · Cited by 3,244
Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913
FRANCIS, C. Y., MORRIS, J., & WHORWELL, P. J. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.142318000.x · Cited by 1,708
Symptomatic atherosclerosis is associated with an altered gut metagenome
Karlsson, F. H., Fåk, F., Nookaew, I., Tremaroli, V., Fagerberg, B., Petranovic, D., Bäckhed, F., & Nielsen, J. (2012) · Nature Communications · doi:10.1038/ncomms2266 · Cited by 1,371
Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects
World Medical Association (WMA) (2009) · Jahrbuch für Wissenschaft und Ethik · doi:10.1515/9783110208856.233 · Cited by 1,087
Postinfectious Irritable Bowel Syndrome
Spiller, R., & Garsed, K. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.074 · Cited by 1,024
Cited by
The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105840 · Cited by 857
D’Amato, A., Di Cesare Mannelli, L., Lucarini, E., Man, A. L., Le Gall, G., Branca, J. J. V., Ghelardini, C., Amedei, A., Bertelli, E., Regoli, M., et al. (2020) · Microbiome · doi:10.1186/s40168-020-00914-w · Cited by 269
“Not surprisingly, faecal microbiota transplant (FMT) is being investigated as a therapeutic option not only for GI-tract-related diseases [13], but also for CNS disorders [14, 15].”
BackgroundCurrent approaches in lipid-based nanocarriers for oral drug delivery
Plaza-Oliver, M., Santander-Ortega, M. J., & Lozano, M. V. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00908-7 · Cited by 249
Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review
Chinna Meyyappan, A., Forth, E., Wallace, C. J. K., & Milev, R. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02654-5 · Cited by 254
“Low Low Zhao 2019 [39] Low Low Low Low Low Kelly 2016 [34] Unclear Unclear Low Low Low Mizuno 2017 [44] Low High Participants and personnel not blinded.”
BackgroundWei, S., Bahl, M. I., Baunwall, S. M. D., Hvas, C. L., & Licht, T. R. (2021) · Applied and Environmental Microbiology · doi:10.1128/aem.00395-21 · Cited by 172
“(18, 19), and this was further lowered by repetitive FMT (17).”
BackgroundFecal Microbiota Transplantation as New Therapeutic Avenue for Human Diseases
Biazzo, M., & Deidda, G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11144119 · Cited by 185
Fecal microbiota transplantation beyond Clostridioides difficile infections
Wortelboer, K., Nieuwdorp, M., & Herrema, H. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.05.066 · Cited by 163
“2) will further disentangle the therapeutic potential of FMT to treat IBS.”
BackgroundInfluentialGutted! Unraveling the Role of the Microbiome in Major Depressive Disorder
Bastiaanssen, T. F. S., Cussotto, S., Claesson, M. J., Clarke, G., Dinan, T. G., & Cryan, J. F. (2020) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000243 · Cited by 159
Western Diet: Implications for Brain Function and Behavior
López-Taboada, I., González-Pardo, H., & Conejo, N. M. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.564413 · Cited by 140
Spichak, S., Bastiaanssen, T. F. S., Berding, K., Vlckova, K., Clarke, G., Dinan, T. G., & Cryan, J. F. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.044 · Cited by 127
Irritable bowel syndrome and gut microbiota
Canakis, A., Haroon, M., & Weber, H. C. (2019) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000523 · Cited by 149
“Yet, improvements in symptoms and quality of life lasted up to 28 weeks [91].”
BackgroundSettanni, C. R., Ianiro, G., Bibbò, S., Cammarota, G., & Gasbarrini, A. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110258 · Cited by 102
Carco, C., Young, W., Gearry, R. B., Talley, N. J., McNabb, W. C., & Roy, N. C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00468 · Cited by 99
Butler, M., Mörkl, S., Sandhu, K. V., Cryan, J. F., & Dinan, T. G. (2019) · The Canadian Journal of Psychiatry · doi:10.1177/0706743719874168 · Cited by 119
Advances in Fecal Microbiota Transplantation for Gut Dysbiosis‐Related Diseases
Hou, S., Yu, J., Li, Y., Zhao, D., & Zhang, Z. (2025) · Advanced Science · doi:10.1002/advs.202413197 · Cited by 117
Zhu, X., Hu, J., Deng, S., Tan, Y., Qiu, C., Zhang, M., Ni, X., Lu, H., Wang, Z., Li, L., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.587670 · Cited by 103
Fecal microbiota transplantation for managing irritable bowel syndrome
El-Salhy, M., & Mazzawi, T. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1447380 · Cited by 77
Self-citationNew insights into irritable bowel syndrome: from pathophysiology to treatment
Hadjivasilis, A., Tsioutis, C., Michalinos, A., Ntourakis, D., Christodoulou, D. K., & Agouridis, A. P. (2019) · Annals of Gastroenterology · doi:10.20524/aog.2019.0428 · Cited by 83
“FMT appears to be effective based on already published studies [128,129].”
MethodBorody, T. J., Eslick, G. D., & Clancy, R. L. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.04.017 · Cited by 64
El‐Salhy, M., Hausken, T., & Hatlebakk, J. G. (2019) · Nutrients · doi:10.3390/nu11061415 · Cited by 62
“It has been shown that administering the transplant to the duodenum is effective [20,25].”
BackgroundMethodSelf-citationMari, A., Baker, F. A., Mahamid, M., Sbeit, W., & Khoury, T. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030685 · Cited by 61
“These findings were further confirmed by other recent studies showing a positive effect on IBS symptoms after transplant, as 70–85% and 45–60% of patients reported symptomatic relief in the first three months and six months after FMT, respectively [81,82].”
ResultLiu, B., Ye, D., Yang, H., Song, J., Sun, X., He, Z., Mao, Y., & Hao, G. (2023) · BMC Gastroenterology · doi:10.1186/s12876-023-02791-7 · Cited by 62
“In addition, the abundance of Actinobacteria showed significant alterations after treatment of IBS [37, 38].”
BackgroundHediyal, T. A., Vichitra, C., Anand, N., Bhaskaran, M., Essa, S. M., Kumar, P., Qoronfleh, M. W., Akbar, M., Kaul-Ghanekar, R., Mahalakshmi, A. M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1324018 · Cited by 59
Wilmes, L., Collins, J. M., O’Riordan, K. J., O’Mahony, S. M., Cryan, J. F., & Clarke, G. A. (2021) · Neurogastroenterology & Motility · doi:10.1111/nmo.14095 · Cited by 54
Ahluwalia, B., Iribarren, C., Magnusson, M. K., Sundin, J., Clevers, E., Savolainen, O., Ross, A. B., Törnblom, H., Simrén, M., & Öhman, L. (2021) · Cells · doi:10.3390/cells10061459 · Cited by 41
“Previous reports evaluating the effects of faecal microbiota transplantation (FMT) from healthy subjects, described that FMT normalized either microbiota [61] or microbiota together with short-chain fatty acids [62] in IBS-D patients and improved IBS symptoms.”
BackgroundMicrobiota in Irritable Bowel Syndrome and Endometriosis: Birds of a Feather Flock Together—A Review
Salmeri, N., Sinagra, E., Dolci, C., Buzzaccarini, G., Sozzi, G., Sutera, M., Candiani, M., Ungaro, F., Massimino, L., Danese, S., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11082089 · Cited by 49
Mazzawi, T. R. E., Hausken, T., Hov, J. R., Valeur, J., Sangnes, D. A., El‐Salhy, M., Gilja, O. H., Hatlebakk, J. G., & Lied, G. A. (2019) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2019.1624815 · Cited by 46
“and patients one week before FMT as described previously [9].”
BackgroundMethodResultInfluentialSelf-citationGut Microbiota Manipulation in Irritable Bowel Syndrome
Mazzawi, T. R. E. (2022) · Microorganisms · doi:10.3390/microorganisms10071332 · Cited by 46
“After performing FMT, the stool will be collected from the recipients and stored in a special freezer at −80 ◦C for further microbial analysis [80].”
BackgroundMethodResultSelf-citationJamshidi, P. K., Farsi, Y., Nariman, Z., Hatamnejad, M. R., Mohammadzadeh, B., Akbarialiabad, H., Nasiri, M. J., & Sechi, L. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914562 · Cited by 40
“Evidence shows that a decrease in abundance of Actinobacteria spp., Bifidobacterium spp., and Lactobacillus spp. in the intestinal bacterial profile is related to IBS symptoms, and increases in Proteobacteria spp. and Escherichia coli have the same effects [53].”
BackgroundGlobal Research Trends in Irritable Bowel Syndrome: A Bibliometric and Visualized Study
Zhang, T., Ma, X., Tian, W., Zhang, J., Wei, Y., Zhang, B., Wang, F., & Tang, X. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.922063 · Cited by 46
“FMT is shown to affect the densities of EECs in the duodenum and colon (83, 84).”
BackgroundUEG Week 2018 Poster Presentations
Pittet, V., Aslan, N., Fournier, N., Decollogny, A., Schoepfer, A., Seibold, F., & Rodondi, P. Y. (2018) · United European Gastroenterology Journal · doi:10.1177/2050640618792819 · Cited by 32
Dietary modulation of gut microbiota for the relief of irritable bowel syndrome
Kim, M.-Y., & Choi, S. (2021) · Nutrition Research and Practice · doi:10.4162/nrp.2021.15.4.411 · Cited by 30
“A fecal microbiota transplantation study involving IBS subjects and healthy donors, who significantly differed in the bacterial strains before transplantation, showed that the transplantation was associated with changes in gut microbiota along with improvement in the symptoms and quality of life, which lasted up to 4…”
BackgroundDuPont, H. L., Jiang, Z., Dupont, A. W., & Utay, N. S. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06102-y · Cited by 31
The role of faecal microbiota transplantation: looking beyond Clostridioides difficile infection
Goldenberg, S. D., & Merrick, B. (2021) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936120981526 · Cited by 36
Kronsten, V. T., & Shawcross, D. L. (2022) · Analytical Biochemistry · doi:10.1016/j.ab.2021.114437 · Cited by 27
Dale, H. F., & Lied, G. A. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2002-57 · Cited by 32
“According to symptom scores, the symptoms were significantly improved following FMT [65].”
BackgroundSelf-citationSchmidt, E. K. A., Raposo, P. J. F., Madsen, K. L., Fenrich, K. K., Kabarchuk, G., & Fouad, K. (2021) · Biology · doi:10.3390/biology10040254 · Cited by 28
Noguera‐Fernández, N., Candela‐González, J., & Orenes‐Piñero, E. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400429 · Cited by 25
The Role of Human Gut Microbe Ruminococcus gnavus in Inflammatory Diseases
Kandasamy, S., Letchumanan, V., Hong, K., Chua, K.-O., Mutalib, N. A., Ng, A. L. O., Ming, L. C., Lim, H. X., Thurairajasingam, S., Law, J. W., et al. (2023) · Progress In Microbes & Molecular Biology · doi:10.36877/pmmb.a0000396 · Cited by 30
Fecal Microbiota Transplant for Hematologic and Oncologic Diseases: Principle and Practice
Zerdan, M. B., Niforatos, S., Nasr, S., Nasr, D., Ombada, M., John, S., Dutta, D., & Lim, S. H. (2022) · Cancers · doi:10.3390/cancers14030691 · Cited by 28
“FMT has also been tried in other conditions, such as in human irritable bowel syndrome [34,35] and autism spectrum disorder [36], and in mice and humans for multiple sclerosis [37,38] and in mice for Parkinson’s disease [39].”
BackgroundKazakevych, J., Denizot, J., Liebert, A., Portovedo, M., Mosavie, M., Jain, P., Stellato, C., Fraser, C. M., Corrêa, R. O., Célestine, M., et al. (2020) · Genome biology · doi:10.1186/s13059-020-01976-7 · Cited by 24
Fecal bacteria and short‐chain fatty acids in irritable bowel syndrome: Relations to subtype
Teige, E. S., Hillestad, E. M. R., Steinsvik, E. K., Brønstad, I., Lundervold, A., Lundervold, A. J., Valeur, J., Hausken, T., Berentsen, B., & Lied, G. A. (2024) · Neurogastroenterology & Motility · doi:10.1111/nmo.14854 · Cited by 27
“23 On the other side, Actinobacteria, Firmicutes ( Bacilli ), Proteobacteria ( Shigella / Escherichia ), and Ruminococcus gna-vus were the predominant bacteria contributing to dysbiosis in the IBS cohort of Casén et al. 4 where all patients ( n = 109) showed an increased signal.”
BackgroundSelf-citationMazzawi, T. R. E., Hausken, T., Refsnes, P. F., Hatlebakk, J. G., & Lied, G. A. (2022) · Microorganisms · doi:10.3390/microorganisms10091819 · Cited by 21
“This route of administration has been safe in all studies [14,21], and did not worsen the DI.”
BackgroundResultInfluentialSelf-citationTeige, E. S., Sortvik, U., & Lied, G. A. (2024) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s451675 · Cited by 12
“Increased levels of Ruminococcus gnavus contributed to the increased dysbiosis in patients with IBS in the study of Casén et al 2015, 10 along with increased levels of Proteobacteria ( Shigella/Escherichia ) and Actinobacteria.”
InfluentialSelf-citationFaber, W., Stolwijk-Swüste, J. M., van Ginkel, F., Nachtegaal, J., Zoetendal, E. G., Winkels, R. M., & Witteman, B. J. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081598 · Cited by 18
“There is some evidence that alteration of the gut microbiota could result in better bowel function in the healthy population, patients with Irritable Bowel Syndrome or SCI [3,19,20].”
BackgroundThe relationship between gut microbiota and proteolytic activity in irritable bowel syndrome
Hou, J., Wang, X., Li, Y., Su, S., Wang, Y., & Wang, B. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104995 · Cited by 19
Beyi, A. F., Wannemuehler, M. J., & Plummer, P. J. (2022) · Antibiotics · doi:10.3390/antibiotics11081093 · Cited by 19
Mazzawi, T. R. E., Hausken, T., & El‐Salhy, M. (2022) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2022.2036809 · Cited by 18
“toms, quality of life and changed the gut microbiota [19] as”
BackgroundSelf-citationMazzawi, T. R. E., El‐Salhy, M., Lied, G. A., & Hausken, T. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.524851 · Cited by 15
“A published study by our group (Mazzawi et al., 2018) has shown that using FMT in IBS patients reduces their symptoms, improves their quality of life within the first week, and restores the imbalance in the gut microbiota within 3 weeks, which lasts for 28 weeks after receiving FMT.”
BackgroundMethodInfluentialSelf-citationQu, Y., Park, S. H., & Dallas, D. C. (2023) · Nutrients · doi:10.3390/nu15183991 · Cited by 15
Wu, D., Zhang, C., Liu, Y., Yao, J., Yang, X., Wu, S., Du, J., & Yang, X. (2023) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2023.02.005 · Cited by 16
An Updated Narrative Mini-Review on the Microbiota Changes in Antenatal and Post-Partum Depression
Doroftei, B., Ilie, O., Diaconu, R., Huțanu, D., Stoian, I. L., & Ilea, C. G. (2022) · Diagnostics · doi:10.3390/diagnostics12071576 · Cited by 12
“[92] reported an improvement for 28 weeks in 13 IBS patients after single FMT through gastro-duodenoscopy in a small placebo-controlled study.”
BackgroundKörner, E., & Lorentz, A. (2023) · Journal of Applied Microbiology · doi:10.1093/jambio/lxad044 · Cited by 10
Qu, Y., Park, S. H., & Dallas, D. C. (2023) · Nutrients · doi:10.3390/nu15194174 · Cited by 11
“Characterized by recurrent abdominal pain, bloating and inconsistent bowel habits, IBS not only disrupts physiological functioning but significantly hampers the quality of life of affected individuals [2,4,5].”
BackgroundMetagenomic analysis of the gut virome in patients with irritable bowel syndrome
Zhang, P., Ma, S., Guo, R., Li, L., Guo, X., Chang, D., Li, S., Zhang, H., Fu, C., Yang, L., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29802 · Cited by 11
“8 Fecal microbiota transplantation (FMT) was able to alter the gut microbial composition in IBS patients, improving symptoms and quality of life in patients 9 ; it also demonstrated the ability to optimize intestinal barrier function and host immunity in animal models.”
Mazzawi, T. R. E., Eikrem, Ø., Lied, G. A., & Hausken, T. (2020) · Gastroenterology Research and Practice · doi:10.1155/2020/3520686 · Cited by 8
“Newly published studies by our group [26, 28] showed that using FMT in patients with diarrhea-predominant IBS (IBS-D) improved their symptoms and changed their gut microbiota profile.”
MethodResultInfluentialSelf-citationChojnacki, J., Popławski, T., Kaczka, A., Romanowska, N., Chojnacki, C. J., & Gąsiorowska, A. (2024) · Nutrients · doi:10.3390/nu16172981 · Cited by 8
“Other researchers have also demonstrated the usefulness of the GA-map Dysbiosis Test, but it was performed mainly in IBS patients [35,60,61].”
ResultNon-pharmacological strategies to treat irritable bowel syndrome: 2022 update
Bonetto, S., Boano, V., VALENZI, E., Saracco, G. M., & Pellicano, R. (2022) · Minerva Gastroenterology · doi:10.23736/s2724-5985.22.03202-8 · Cited by 7
Plantinga, A., Kamp, K., Wu, Q., Chen, L., Yoo, L., Burr, R. L., Cain, K. C., Raftery, D., Neto, F. C., Badu, S., et al. (2023) · Neurogastroenterology & Motility · doi:10.1111/nmo.14545 · Cited by 8
Poortmans, P. J., & Kindt, S. (2020) · VUBIR (Vrije Universiteit Brussel) · Cited by 9
Trinh, S., Keller, L., Herpertz‐Dahlmann, B., & Seitz, J. (2023) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917/a000928 · Cited by 5
Fecal Microbiome Transplantation: An Offhand Recipe for Microbiome Therapeutics
Radhakrishanan, A., Kakkar, P., Tandon, C., & Srivastav, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00001-2 · Cited by 4
García-Mazcorro, J. F., Amieva‐Balmori, M., Triana‐Romero, A., Wilson, B., Smith, L., Reyes-Huerta, J., Rossi, M., Whelan, K., & Remes-Troche, J. M. (2023) · Microorganisms · doi:10.3390/microorganisms11102493 · Cited by 5
Chen, T., Tang, Q., Yu, B., Tang, L., Lin, J., Zhang, L., Shan, W., & Yu, H. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120505 · Cited by 4
Qadir, S. A., ALKaisy, Q. H., Hasan, A. F., Awlqadr, F. H., Altemimi, A. B., Faraj, A. M., Giuffrè, A. M., Saeed, M. N., & Abdalla, S. R. (2024) · Kurdistan Journal of Applied Research · doi:10.24017/science.2024.2.6 · Cited by 3
“[47] Colonoscopy FMT is effective in PI-IBS; significant microbiota changes and symptom relief observed.”
BackgroundPsychobiotics: Biotherapeutics for Positive Mental Health
Mörkl, S., Butler, M., Cichini, F., Cryan, J. F., & Dinan, T. G. (2020) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190931544.013.7 · Cited by 3
Gut Microbiome and Gastrointestinal Disorders
Legaki, E., Karanasou, E. A., & Gazouli, M. (2021) · The microbiomes of humans, animals, plants, and the environment · doi:10.1007/978-3-030-59642-2_3 · Cited by 2
Modern approaches to the essence and assessment of gut dysbiosis. Review
Ткач, С. М., Dorofeev, A. E., & Dorofeeva, G. A. (2022) · Modern Gastroenterology · doi:10.30978/mg-2022-5-58 · Cited by 3
Lee, H.-K., Shin, C. M., Chang, Y. H., Jo, H., Choi, J., Choi, Y., Jun, Y. K., Yoon, H., Park, Y. S., Kim, N., et al. (2025) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm24183 · Cited by 5
“24,25 Notably, this study advances these findings by demonstrating a significant statistical correlation between the donor-recipient microbiome similarity and IBS symptom improvements, offering a novel insight.”
Hamblin, H. S., Gunaratne, A. W., Clancy, A. K., Pilarinos, D., Busque, A. L., Dawson, M. V. M., & Borody, T. J. (2022) · Gastroenterology Research and Practice · doi:10.1155/2022/6083896 · Cited by 3
“Two studies have also reported significant improvement in the short term and long term of IBS symptoms and changes to the gut microbiota [56, 57].”
BackgroundProbiotics and fecal bacteriotherapy: The line between deception and treating
Smieško, G., Gusman, V., Banović, P., & Mikov, M. (2020) · Vojnosanitetski pregled · doi:10.2298/vsp191018008s · Cited by 1
The use of fecal microbiota transplantation in the treatment of intestinal diseases
Ręka, G., Nowak, E., Psiuk, D., Rocka, A. A., & Piecewicz‐Szczęsna, H. (2020) · Journal of Education Health and Sport · doi:10.12775/jehs.2020.10.09.082 · Cited by 1
“Before FMT there were significant differences in the profile of bacterias Ruminococcus gnavus, Actinobacteria i Bifidobacteria in the stool between two groups.”
BackgroundPenton, C. R., & Vadakattu, G. (2026) · PNAS Nexus · doi:10.1093/pnasnexus/pgag132 · Cited by 1
“FMT has also been used to significantly ameliorate depression and anxiety symptoms (275) with a meta-analysis (276) finding significant short-term improvement in depression, though long-term effects were less consistent (277, 278).”
Ghasemzadeh, Y. (2024) · Qapsule Queen s Undergraduate Health Sciences Journal · doi:10.24908/qap.v1i2.17348 · Cited by 1
Irritable Bowel Syndrome: Current and Emerging Therapies
Starkweather, A. R. (2019) · Topics in Pain Management · doi:10.1097/01.tpm.0000579832.72003.7e
Lujiao, G., Niu, X., Niu, T., Wang, X., Lu, X., Hong, J.-W., Feng, Q., Yang, X., & González, R. (2020) · Journal of Traditional Chinese Medical Sciences · doi:10.1016/j.jtcms.2020.04.005 · Cited by 1
Zhou, C., Yi, Y., Taishi, Y., Wang, L., & Qu, J. (2023) · Research Square · doi:10.21203/rs.3.rs-3090202/v1
Fecal Microbiota Transplantation for Treatment of Irritable Bowel Syndrome
Yamane, T., Masaoka, T., & Kanai∥, T. (2024) · Springer eBooks · doi:10.1007/978-981-97-8410-3_17
de Menezes, R. V., Lapenda, J. F. D. P. P., Knopp, A. G., Ferreira, M. S., Campos, F. L. B. O., Costa, M., Crusco, G. S., Ferreira, A. L. M. M., & Silva, H. R. D. S. E. (2025) · Brazilian Medical Students · doi:10.53843/bms.v10i14.742
Personality Disorders and the Gut Microbiota: A New Narrative
Rangraze, I. R. (2024) · Springer eBooks · doi:10.1007/978-3-031-32035-4_109-1
Fecal microbiota transplantation in patients with irritable bowel syndrome
Miranda-Guzmán, Y. A., Landetta-Platonoff, J. A., & Schmulson, M. J. (2025) · NeuroGastroLATAM Reviews · doi:10.24875/ngl.24000001 · Cited by 1
Mifsud, M. M. (2025) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.905
Personality Disorders and the Gut Microbiota: A New Narrative
Rangraze, I. R. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_109 · Cited by 2
Forde, F. (2025) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/1gzb-2akp · Cited by 1
D’Amato, A., Mannelli, L. D. C., Lucarini, E., Man, A. L., Le Gall, G., Branca, J. J. V., Ghelardini, C., Amedei, A., Bertelli, E., Regoli, M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13041006
D’Amato, A., Mannelli, L. D. C., Lucarini, E., Man, A. L., Le Gall, G., Branca, J. J. V., Ghelardini, C., Amedei, A., Bertelli, E., Regoli, M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13041009
Kazakevych, J., Denizot, J., Liebert, A., Portovedo, M., Mosavie, M., Jain, P., Stellato, C., Fraser, C. M., Corrêa, R. O., Célestine, M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.11972577
D’Amato, A., Mannelli, L. D. C., Lucarini, E., Man, A. L., Le Gall, G., Branca, J. J. V., Ghelardini, C., Amedei, A., Bertelli, E., Regoli, M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13040958
Kazakevych, J., Denizot, J., Liebert, A., Portovedo, M., Mosavie, M., Jain, P., Stellato, C., Fraser, C. M., Corrêa, R. O., Célestine, M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.11972538
Kazakevych, J., Denizot, J., Liebert, A., Portovedo, M., Mosavie, M., Jain, P., Stellato, C., Fraser, C. M., Corrêa, R. O., Célestine, M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.11972583
Liu, B., Ye, D., Yang, H., Song, J., Sun, X., He, Z., Mao, Y., & Hao, G. (2023) · Figshare · doi:10.6084/m9.figshare.22814916
Meyyappan, A. C. (2020) · QSpace (Queen's University Library)
Ulosteensiirto masennuksen oireiden hoitokeinona
Pakka, N., & Korpimies, O. (2025) · UTUPub (University of Turku)
Investigating the Physiological Effects of Gut Therapeutics in a Psychiatric Popualtion
Forth, E. (2025) · QSpace (Queen's University Library)
Topics, Gut Microbiota and Functional Bowel Disorders
Masaoka, T. (2026) · Springer eBooks · doi:10.1007/978-981-95-6974-8_54
Couturier, J. L., Kenner, E., Nicula, M., Chowdhury, F., Surette, M., & Pai, N. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-109115
Yan, Q., Li, M., Wang, G., Zhang, A., Li, Y., Guo, R., Zhang, Y., Yang, W., Zhang, Y., Liu, X., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08269-w
“Irritable bowel syndrome (IBS) is a prevalent chronic gastrointestinal disorder that affects approximately 10–20% of the adult population worldwide, contributing to substantial morbidity and significant socioeconomic burdens [1].”
Song, X., Huang, D., Liu, S., Ye, X., Zhong, Q., Wang, Y., Lai, S., Zhong, S., & Jia, Y. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122332
Metadata
- Authors
- Mazzawi, T., Lied, G. A., Sangnes, D. A., El-Salhy, M., Hov, J. R., Gilja, O. H., Hatlebakk, J. G., & Hausken, T.
- Affiliations
- Haukeland University Hospital (NO)
- Oslo University Hospital (NO)
- Corresponding author
- Mazzawi, Tarek
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-11-14
- Volume
- 13
- Issue
- 11
- Pages
- e0194904
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC6235238
- OpenAlex
- W2900510600
- Cited by
- 92
- References
- 58
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 10 · 2023: 13 · 2022: 11 · 2021: 16 · 2020: 22 · 2019: 9 · 2018: 2
- FWCI
- 11.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Helse Vest Regionalt Helseføretak (911802)
- Norwegian Research Council (240787/F20)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- irritable bowel syndrome, fecal microbiota transplantation, gut microbiota composition, microbiota dynamics, dysbiosis, Ruminococcus gnavus, Bifidobacterium, quality of life, anxiety and depression
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Adolescent, Adult, Aged, Feces, Female, Humans, Male, Middle Aged, Quality of Life, Irritable Bowel Syndrome, Young Adult, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.